EP2575820A4 - Darreichungsform mit kontrollierter freisetzung mit quetiapin - Google Patents

Darreichungsform mit kontrollierter freisetzung mit quetiapin

Info

Publication number
EP2575820A4
EP2575820A4 EP11785946.2A EP11785946A EP2575820A4 EP 2575820 A4 EP2575820 A4 EP 2575820A4 EP 11785946 A EP11785946 A EP 11785946A EP 2575820 A4 EP2575820 A4 EP 2575820A4
Authority
EP
European Patent Office
Prior art keywords
quetiapine
dosage form
controlled release
release dosage
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11785946.2A
Other languages
English (en)
French (fr)
Other versions
EP2575820A1 (de
Inventor
Ma David Wai Fung
Prashant Manohar Mandaogade
Naresh Talwar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmascience Inc
Original Assignee
Pharmascience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmascience Inc filed Critical Pharmascience Inc
Publication of EP2575820A1 publication Critical patent/EP2575820A1/de
Publication of EP2575820A4 publication Critical patent/EP2575820A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP11785946.2A 2010-05-27 2011-05-27 Darreichungsform mit kontrollierter freisetzung mit quetiapin Withdrawn EP2575820A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2705685A CA2705685A1 (en) 2010-05-27 2010-05-27 Pharmaceutical dosage form containing an antipsychotic agent
PCT/CA2011/000620 WO2011147025A1 (en) 2010-05-27 2011-05-27 Controlled release dosage form comprising quetiapine

Publications (2)

Publication Number Publication Date
EP2575820A1 EP2575820A1 (de) 2013-04-10
EP2575820A4 true EP2575820A4 (de) 2014-01-08

Family

ID=45003170

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11785946.2A Withdrawn EP2575820A4 (de) 2010-05-27 2011-05-27 Darreichungsform mit kontrollierter freisetzung mit quetiapin

Country Status (4)

Country Link
EP (1) EP2575820A4 (de)
CA (2) CA2705685A1 (de)
SG (1) SG187172A1 (de)
WO (1) WO2011147025A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014155387A1 (en) * 2013-03-24 2014-10-02 Tushar Patel Extended release dosage forms of quetiapine salts

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005041935A1 (en) * 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
US20090317473A1 (en) * 2008-06-20 2009-12-24 Naringrekar Gandha V Controlled-release formulations, method of manufacture, and use thereof
EP2153834A2 (de) * 2008-08-07 2010-02-17 Farmaprojects, S.A. Pharmazeutische Zusammensetzungen mit anhaltender Freisetzung, die Quetiapinsalze umfassen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090035370A1 (en) * 2007-08-02 2009-02-05 Drugtech Corporation Dosage form and method of use
US7794750B2 (en) * 2008-06-20 2010-09-14 Mutual Pharmaceutical Company, Inc. Controlled-release formulations, method of manufacture, and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005041935A1 (en) * 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
US20090317473A1 (en) * 2008-06-20 2009-12-24 Naringrekar Gandha V Controlled-release formulations, method of manufacture, and use thereof
EP2153834A2 (de) * 2008-08-07 2010-02-17 Farmaprojects, S.A. Pharmazeutische Zusammensetzungen mit anhaltender Freisetzung, die Quetiapinsalze umfassen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011147025A1 *

Also Published As

Publication number Publication date
SG187172A1 (en) 2013-02-28
WO2011147025A1 (en) 2011-12-01
CA2800910A1 (en) 2011-12-01
EP2575820A1 (de) 2013-04-10
CA2705685A1 (en) 2011-11-27

Similar Documents

Publication Publication Date Title
ZA201304158B (en) Dosage form
GB0909680D0 (en) Dosage form
ZA201400310B (en) Solid dosage form
EP2714015A4 (de) Feste dosierungsformen mit gesteuerter freisetzung
HK1167809A1 (en) Oxidation-stabilized tamper-resistant dosage form
ZA201307862B (en) Controlled release pharmaceutical dosage forms
GB201217619D0 (en) Pulsatile drug release
GB201003581D0 (en) Medicament dispenser
GB201010193D0 (en) Medicinal use
EP2437733A4 (de) Retard-darreichungsform
GB201019354D0 (en) Prothesis
PL2554168T3 (pl) Kompozycja farmaceutyczna do kontrolowanego uwalniania
PL2726064T3 (pl) Doustna postać użytkowa o kontrolowanym uwalnianiu zawierająca oksykodon
GB201001762D0 (en) Medicament dispenser
HK1179164A1 (zh) 包含肉豆蔻酰氨基丙基二甲基苄基氯化銨的藥物製劑
EP2575820A4 (de) Darreichungsform mit kontrollierter freisetzung mit quetiapin
GB201018917D0 (en) Dosage form
GB201011271D0 (en) Dosage Form
GB201016615D0 (en) Drug release composition
GB201001317D0 (en) Medicament
GB201001335D0 (en) Drug release formulations
PL390434A1 (pl) Preparat leczniczy
GB201011960D0 (en) Implant
GB201002117D0 (en) Implant
PL118869U1 (pl) Zasobnik medyczny

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20121206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131209

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20131203BHEP

Ipc: A61K 47/12 20060101ALI20131203BHEP

Ipc: A61K 31/554 20060101AFI20131203BHEP

Ipc: A61K 9/16 20060101ALI20131203BHEP

Ipc: A61K 47/44 20060101ALI20131203BHEP

Ipc: A61P 25/18 20060101ALI20131203BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1183825

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20161201

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1183825

Country of ref document: HK